Drug establishment registration
GlaxoSmithKline LLC
FDA drug establishment · DUNS 149372109 · FEI 1033964 · USA
Key facts
| Firm name | GlaxoSmithKline LLC |
|---|---|
| DUNS number | 149372109 |
| FEI number | 1033964 |
| Address | 1011 North Arendell Ave, Zebulon, North Carolina (NC) 27597, United States (USA) |
| Country | USA |
| Business operations | ANALYSIS, LABEL, MANUFACTURE, PACK |
| Registration valid through | Dec 31, 2026 |
At a glance
- Current Registration current
- 10–99 FDA inspections at this FEI
- 10–99 Inspections with a Form 483
- None Warning letters
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug establishment registrations
Establishments that manufacture, repack, relabel or analyze drugs for the U.S. market register with the FDA each year. The registration lists the site's DUNS and FEI numbers and its business operations.
Source: U.S. Food and Drug Administration (FDA), Drug Establishments Current Registration Site (DECRS)